Inozyme Pharma, Inc.
INZYDelisted Jul 1, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001693011
Inozyme Pharma, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 3, 2025; 87 institutions reported holding it in 13F filings for Q2 2025, worth $202.3M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Inozyme Pharma, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 51
- −1 vs. Q3 2021
- Shares held
- 17.3M
- −155.8K (−0.9%) vs. Q3 2021
- Total value
- $118.2M
- −$84.5M (−41.7%) vs. Q3 2021
- New holders
- 8
- 17 more added
- Sold out
- 9
- 14 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INZY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 87 | $202.3M |
| Q1 2025 | 97 | $42.5M |
| Q4 2024 | 105 | $145.1M |
| Q3 2024 | 89 | $285.5M |
| Q2 2024 | 90 | $240.1M |
| Q1 2024 | 89 | $382.0M |
| Q4 2023 | 80 | $213.3M |
| Q3 2023 | 77 | $204.6M |
| Q2 2023 | 74 | $190.3M |
| Q1 2023 | 50 | $183.4M |
| Q4 2022 | 37 | $30.4M |
| Q3 2022 | 39 | $82.7M |
| Q2 2022 | 47 | $149.4M |
| Q1 2022 | 50 | $71.2M |
| Q4 2021 | 51 | $118.2M |
| Q3 2021 | 52 | $202.7M |
| Q2 2021 | 50 | $337.1M |
| Q1 2021 | 55 | $379.4M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Inozyme Pharma, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Toronto Dominion Bank | 2 | $0 | 0.00% | +2 | New |
| Federated Hermes, Inc. | 121 | $1.00K | 0.00% | +121 | New |
| Ameritas Investment Partners, Inc. | 692 | $5.00K | 0.00% | 00.0% | Unchanged |
| Amplius Wealth Advisors, LLC | 1,000 | $6.00K | 0.00% | +1,000 | New |
| Legal & General Group Plc | 1,147 | $8.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,402 | $10.0K | 0.00% | +597+74.2% | Added |
| Royal Bank of Canada | 3,011 | $20.0K | 0.00% | +1,170+63.6% | Added |
| Acadian Asset Management LLC | 3,676 | $25.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 3,664 | $25.0K | 0.00% | +560+18.0% | Added |
| New York State Common Retirement Fund | 3,834 | $26.0K | 0.00% | −6,619−63.3% | Reduced |
| UBS Group AG | 7,228 | $49.0K | 0.00% | +7,228 | New |
| American International Group, Inc. | 7,647 | $52.0K | 0.00% | −228−2.9% | Reduced |
| California State Teachers Retirement System | 7,730 | $53.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 7,983 | $54.0K | 0.00% | +7,935+16,531.3% | Added |
| Deutsche Bank AG | 8,728 | $60.0K | 0.00% | +452+5.5% | Added |
| Bank of America Corp | 11,853 | $81.0K | 0.00% | +11,566+4,030.0% | Added |
| Ergoteles LLC | 12,200 | $83.0K | 0.00% | +12,200 | New |
| Rhumbline Advisers | 13,064 | $89.0K | 0.00% | −398−3.0% | Reduced |
| Goldman Sachs Group Inc | 13,239 | $90.0K | 0.00% | −3,326−20.1% | Reduced |
| Laurion Capital Management LP | 13,390 | $91.0K | 0.00% | −57,310−81.1% | Reduced |
| Walleye Capital LLC | 15,588 | $106.0K | 0.00% | +15,588 | New |
| Overbrook Management Corp | 16,726 | $114.0K | 0.02% | 00.0% | Unchanged |
| Morgan Stanley | 19,440 | $133.0K | 0.00% | +1,446+8.0% | Added |
| Millennium Management LLC | 19,952 | $136.0K | 0.00% | +8,888+80.3% | Added |
| Marshall Wace, LLP | 36,033 | $247.0K | 0.00% | +2,625+7.9% | Added |
| Charles Schwab Investment Management Inc | 36,427 | $249.0K | 0.00% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 42,261 | $251.0K | 0.00% | −5,401−11.3% | Reduced |
| Bank of New York Mellon Corp | 41,196 | $281.0K | 0.00% | +778+1.9% | Added |
| Bridgeway Capital Management, LLC | 77,400 | $528.0K | 0.01% | +77,400 | New |
| Jacobs Levy Equity Management, Inc | 88,921 | $606.0K | 0.00% | +67,884+322.7% | Added |
| Citadel Advisors LLC | 106,978 | $729.0K | 0.00% | +12,512+13.2% | Added |
| Baker Bros. Advisors LP | 106,999 | $730.0K | 0.00% | 00.0% | Unchanged |
| Caas Capital Management LP | 113,091 | $771.0K | 0.07% | −22,307−16.5% | Reduced |
| Northern Trust Corp | 120,762 | $823.0K | 0.00% | +4,661+4.0% | Added |
| Janus Henderson Group PLC | 125,153 | $857.0K | 0.00% | +125,153 | New |
| Geode Capital Management, LLC | 184,019 | $1.25M | 0.00% | −14,605−7.4% | Reduced |
| State Street Corp | 187,102 | $1.28M | 0.00% | −1,165−0.6% | Reduced |
| MPM Oncology Impact Management LP | 302,615 | $2.06M | 0.38% | −18,109−5.6% | Reduced |
| JPMorgan Chase & Co | 324,387 | $2.21M | 0.00% | −7,504−2.3% | Reduced |
| Vanguard Group Inc | 488,719 | $3.33M | 0.00% | −122,466−20.0% | Reduced |
| OrbiMed Advisors LLC | 526,600 | $3.59M | 0.05% | +232,600+79.1% | Added |
| FMR LLC | 609,380 | $4.16M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 836,998 | $5.71M | 0.00% | −63,721−7.1% | Reduced |
| Rock Springs Capital Management LP | 868,466 | $5.92M | 0.14% | +18,451+2.2% | Added |
| CHI Advisors LLC | 892,057 | $6.08M | 2.02% | −28,207−3.1% | Reduced |
| Suvretta Capital Management, LLC | 1,013,216 | $6.91M | 0.13% | +26,816+2.7% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,591,154 | $10.9M | 4.54% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,599,028 | $10.9M | 0.02% | +131,200+8.9% | Added |
| Sofinnova Investments, Inc. | 2,028,308 | $13.8M | 0.89% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 2,344,786 | $16.0M | 0.34% | 00.0% | Unchanged |
| NEA Management Company, LLC | 2,444,379 | $16.7M | 0.34% | 00.0% | Unchanged |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −364,600−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −115,516−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −65,781−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −11,611−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −7,991−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −7,000−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −540−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −44−100.0% | Sold out |